Adam Van Dyke

Grant Program Specialist, Dipole Materials

Dr. Adam Van Dyke has a background in neuroscience and psychology and leads grant writing efforts for Dipole Materials, Inc. Holding a Ph.D. from UMD, his technical know-how extends from the laboratory space to the marketplace. He is also the founder of Asulon Therapeutics, a virtually integrated pharmaceutical company that focuses on the rapid treatment of mood disorders through the development of small molecule therapeutics. His research experience spans the fields of translational medicine, neuroscience, and entrepreneurship. Van Dyke specializes in bringing our ideas at Dipole from conception to reality